Krystexxa pegloticase is not recommended for the treatment of asymptomatic hyperuricemia. Krystexxa 8 mg concentrate for solution for infusion. See full prescribing information for complete boxed warning. Pegloticase krystexxa injectable aetna precertification. Krystexxa pegloticase is proven for the treatment of chronic gout refractory to. You are encouraged to report negative side effects of prescription drugs to the. Krystexxa pegloticase injection for intravenous infusion. Krystexxa is a clear, colorless, sterile 8 mgml solution of pegloticase in a 2 ml singleuse vial, expressed as amounts of uricase protein. The potency of this product should not be compared to the one of another pegylated or nonpegylated protein of the.
Withhold or discontinue imfinzi to manage adverse reactions as described in table 2. Learn more about clinical trial data, safety, dosing, and patient access. Cimzia is a biologic treatment for multiple chronic inflammatory conditions. Chapter 7a prescription medications prior authorization number. Read the medication guide provided by your pharmacist before you start using pegloticase and each time you get a refill. However it is recommended that diluted solutions be stored under refrigeration, not frozen, protected from light, and used within 4 hours of dilution. Works directly with the office to support reimbursement questions and works. These highlights do not include all the information needed to. Pegloticase is a protein that is designed to treat severe chronic gout when other more common treatments have failed or. Dailymed krystexxa pegloticase injection, solution. Aug 22, 2019 krystexxa is supplied as a clear, colorless, sterile solution in phosphate buffered saline intended for intravenous infusion after dilution.
Krystexxa is indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Krystexxa, innpegloticase european medicines agency. The complete flumazenil package insert including contraindications, warnings, and precautions should be consulted prior to use. Diazepam injection fda prescribing information, side. Sep 15, 2012 1 95% confidence interval for differences in responder rate between pegloticase group vs. Krystexxa is usually given after other gout medications have been tried without successful treatment of symptoms. Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for vimpat lacosamide. Important reminder the purpose of this medical policy is to provide a guide to coverage. Page 3 of 4 service request form krystexxaconnect please fax completed form with a copy of the front and back of the patients insurance card. Patients should be closely monitored for an appropriate period of time for anaphylaxis after administration of krystexxa. Highlights of prescribing information these highlights do not include all the information needed to use injectafer safely and effectively. Full prescribing information 1 indications and usage copaxone is indicated for the treatment of relapsing forms of multiple sclerosis ms, to include clinically isolated syndrome, relapsingremitting disease, and active secondary progressive disease, in adults.
See full prescribing information including boxed warning on serious infections. Monitor patients and discontinue rituxan infusion for severe reactions 5. When possible, interrupt therapy with brilinta for fivedays prior to surgery that has a major risk of bleeding. Systematic nonpharmacololgic and pharmacologic therapeutic approatches to hyperuricemia. Krystexxa is a clear, colorless, sterile 8 mgml solution of pegloticase in a 2 ml singledose vial, expressed as amounts of uricase protein. Please accept our privacy terms we use cookies and similar technologies to. Approximately 24 hours following the first dose of krystexxa, mean plasma uric acid levels for subjects in the krystexxa groups were 0. Highlights of prescribing information may worsen during. This was a business decision and was not related to any efficacy, safety or clinical concerns with lesinurad.
Your primary krystexxa contact, daytoday account specialist, and resource to help meet all of your needs. Krystexxa sgm p2017 cvs caremark is an independent company that provides pharmacy benefit management services to carefirst bluecross blueshield and carefirst bluechoice, inc. Use outside of these guidelines may result in nonpayment unless approved under an exception process. Krystexxa pegloticase injection for intravenous infusion is an enzyme that metabolizes uric acid into a harmless chemical that is eliminated from the body in urine and is used to treat chronic gout. Highlights of prescribing information an initial dose. Gout is a common arthritis caused by deposition of monosodium urate crystals within joints that can also deposit in tissues and the kidneys. Oct 02, 2019 methotrexate package insert pdf to more effectively utilize new gout drug, krystexxa, approved search go. Krystexxa should be administered in healthcare settings and by healthcare providers prepared to manage anaphylaxis and infusion reactions. In comparison, the mean plasma uric acid level for the placebo group was 8. Krystexxa fda prescribing information, side effects and uses. The information in this policy is used by wellmark to make determinations whether medical treatment is covered under the terms of a wellmark members health benefit plan.
Prescribing information, including boxed warning, and medication guide. Serious allergic reactions may happen in some patients who receive krystexxa. Visually inspect krystexxa for pariculate matter and discoloration before administration, whenever solution and container permit. Severe mucocutaneous reactions, some with fatal outcomes 5. Krystexxa pegloticase is covered under the medical benefit when used within the following guidelines. Fdaapproved package labeling or a medically accepted indication. Krystexxa pegloticase injection, for intravenous infusion. Erratum to the rheumatology of gout advances in chronic. Please refer to the hmsa medical policy web site for the fax form. John albert, a rheumatologist at the rheumatic disease center in southeastern wisconsin, discusses a new inpractice patient series presented at the american college of. Is prescribed a dose and duration of therapy that is consistent with fdaapproved package. Krystexxa is supplied in a singleuse 2 ml glass vial with a teflon coated latexfree rubber injection stopper to deliver krystexxa as 8 mg of uricase protein in 1 ml volume.
Dosage forms and strengths 3 use appropriate aseptic technique. Zurampic prescribing information ironwood discontinued u. Beovu brolucizumabdbll injection is a treatment for wet agerelated macular degeneration wet amd. Service request form krystexxaconnect please fax completed form with a copy of the front and back of the patients insurance card. Please accept our privacy terms we use cookies and similar technologies to improve your browsing experience, personalize content and offers, show targeted ads, analyze traffic, and better understand you. Based on posthoc analyses of the clinical trial data, if krystexxa had been stopped when a patients uric acid level rose to greater than 6 mgdl on a single. These highlights do not include all the information needed to use uloric safely and effectively. Krystexxa is supplied as a clear, colorless, sterile solution in phosphate buffered saline intended for intravenous infusion after dilution.
Fatal infusionrelated reactions within 24 hours of rituxan infusion. Krystexxa is a prescription medicine used in adults to help reduce the signs and symptoms of gout that are not controlled by other treatments. What is the most important information i should know about krystexxa pegloticase. Highlights of prescribing information these highlights do not include all the information needed to use sutent safely and effectively. Krystexxa diluted in infusion bags is stable for 4 hours at 2.
Dosage and administration approvals may be subject to dosing limits in accordance with fda approved labeling, accepted compendia, andor evidencebased practice guidelines. Methotrexate and krystexxa pegloticase study for chronic. Carefirst bluecross blueshield is the shared business name of carefirst of maryland, inc. Storage and handling before the preparation for use, krystexxa must be stored in the carton and maintained at all times under refrigeration between 2 to 8c 36 to 46f. Chronic hyperuricemia is the most important risk factor for. Not to be copied, reproduced or distributed without the expressed prior knowledge, consent and permission of avmed. Abraxane is 125 mgm2 intravenously over 3040 minutes on days 1, 8 and 15 of each 28day cycle. Gout is a common arthritis caused by deposition of monosodium urate crystals within joints that can also. Dosage the recommended dose and regimen of krystexxa for adult patients is 8 mg uricase protein given as an intravenous infusion every two weeks. Krystexxa will not be used concomitantly with oral uratelowering therapies b. Kr ystexxatm pegloticase is a pegylated uric acid specific enzyme indicated. Krystexxa is not recommended for the treatment of asymptomatic hyperuricemia. The optimal treatment duration with krystexxa has not been established. Do not administer krystexxa to patients with g6pd deficiency.
Highlights of prescribing information an initial dose of 600. Side effects of krystexxa pegloticase injection, warnings, uses. Highlights of prescribing information these highlights do not include all the information needed to use dupixent safely and effectively. Aetna precertification notification 503 sunport lane, orlando, fl 32809 phone. Member has had an inadequate response to or a clinical reason for not completing at least a threemonth trial see. Krystexxa pegloticase is a pegylated uric acid specific enzyme indicated for. Methotrexate package insert pdf to life in pills2020. Dupixent dupilumab injection, for subcutaneous use initial u. Unitedhealthcare commercial medical benefit drug policy. Member has had an inadequate response to or a clinical reason for not completing at least a threemonth trial see appendix with the following medications at the medically appropriate maximum doses. Please see full prescribing information, including boxed warning.
Easy to read fda package insert, drug facts, dosage and administration, and adverse effects for vimpat lacosamide skip to. The information in this policy is used by wellmark to make determinations whether. Please see the medication guide and prescribing information for more information. Sep 16, 2019 krystexxa diluted in infusion bags is stable for 4 hours at 2. A fieldbased clinical and medical expert pharmd, phd, or md on horizon medicines. Krystexxa pegloticase notice this policy contains information which is clinical in nature. In the article the rheumatology of gout sundy js, advances in chronic kidney disease 19.
The effect of ambien may be slowed by ingestion with or immediately after a meal. Full prescribing information 1 indications and usage copaxone is indicated for the treatment of relapsing forms of multiple sclerosis ms, to include clinically isolated syndrome. Use outside of these guidelines may result in nonpayment unless approved under an exception. Patients should be premedicated with antihistamines and corticosteroids. Atgam lymphocyte immune globulin, antithymocyte globulin equine sterile solution this product information is intended only for residents of the united states. Cimzia certolizumab pegol an fdaapproved biologic treatment.
1291 1200 501 945 955 44 1264 459 1214 43 571 362 1267 43 694 905 958 202 633 806 46 51 1151 1538 1038 706 977 1445 1021 207 1420 1055 54 665 1133 1380 740 35 314